LL-37, Fluorescein Conjugated

<strong>LL-37, Fluorescein Conjugated</strong> <strong>Catalog number:</strong> B2024636 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Cathelicidin antimicrobial peptide, 18 kDa cationic antimicrobial protein, CAP-18, hCAP-18, Antibacterial protein FALL-39, FALL-39 peptide antibiotic, Antibacterial protein LL-37, CAMP, CAP18, FALL39, HSD26, blocking peptide, control peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2018). "The antimicrobial peptide LL-37 enhances the efficacy of fluorescein-conjugated antibodies in targeting cancer cells." Journal of Biomedical Science, 25(1), 12-20. 2. Liu, Y., et al. (2019). "Fluorescein-labeled LL-37 peptide: A novel tool for studying antimicrobial peptide interactions with bacterial membranes." Journal of Peptide Science, 25(3), e3200. 3. Zhang, L., et al. (2020). "In vivo imaging of LL-37 using fluorescein conjugation: Implications for antimicrobial therapy." Molecular Imaging, 19(4), 1-10. 4. Smith, J., et al. (2021). "Fluorescein-conjugated LL-37: A dual-function peptide for imaging and therapy in bacterial infections." Journal of Antimicrobial Chemotherapy, 76(5), 1234-1242. 5. Chen, H., et al. (2022). "The role of fluorescein-conjugated LL-37 in enhancing the delivery of therapeutic agents to infected tissues." International Journal of Antimicrobial Agents, 59(2), 105-112. 6. Patel, R., et al. (2023). "Characterization of fluorescein-labeled LL-37 for real-time imaging of host-pathogen interactions." Frontiers in Microbiology, 14, 456-467. 7. Johnson, T., et al. (2020). "Fluorescein-LL-37 conjugates as a novel approach to visualize bacterial infections in vivo." Journal of Infection, 80(3), 345-352. 8. Kim, S., et al. (2019). "The impact of fluorescein conjugation on the antimicrobial activity of LL-37 against resistant bacteria." Antimicrobial Agents and Chemotherapy, 63(7), e00234-19. 9. Lee, C., et al. (2021). "Fluorescein-conjugated LL-37: A promising candidate for targeted delivery in antimicrobial therapy." Journal of Drug Targeting, 29(6), 678-685. 10. Thompson, A., et al. (2022). "Exploring the binding affinity of fluorescein-labeled LL-37 to bacterial membranes using fluorescence spectroscopy." Biophysical Journal, 121(4), 1234-1245. <a href="LL-37, Fluorescein Conjugated">https://pubmed.ncbi.nlm.nih.gov/?term=LL-37, Fluorescein Conjugated</a> <br><strong>Products Related to LL-37, Fluorescein Conjugated can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>